An estimated US $128 billion of branded revenues will face generic competition from 2009 to 2014. Meanwhile, development time and costs of production continue to rise, reaching between $800 million and $2 billion over eight or more years (Pharmaceutical Executive Magazine, December 2009).

In the current environment, companies are faced with reducing costs, increasing regulatory oversight, heightened competition and the growing role payors are playing in the planning/decision making process.   In order to succeed, companies will need to reevaluate their current commercialization strategies to understand the new risks and how to take advantage of the new opportunities that are created. 

CBI has continually been recognized as the leader in providing commercialization events that offer best practices, superior content and robust networking.  This premier summit combines some of our thought provoking forums to provide exclusive coverage of all aspects of the commercialization process.  Leaders within new product planning, managed care, reimbursement, brand management, strategic pricing and marketing have the opportunity to participate in case study driven workshops, keynote presentations as well as breakout exchanges that afford the opportunity to engage in discussion of the practical issues behind these programs.  The conference focuses on novel models for commercialization that respond to the new economic landscape while accounting for the changing relationship between patients, physicians and payors.

The industry gathers in December – Will you be there?

Sponsors/Exhibitors:

Educational Sponsors:	For pharmaceutical manufacturers, healthcare organizations, physicians, payers and patients, AmerisourceBergen Specialty Group is an essential business partner. We lead the market in oncology, plasma- erivative and biotech product distribution. Dozens of the largest and most respected manufacturers in the industry rely on us for services like outsourced logistics, reimbursement consulting and compliance management. We work with our partners to improve access and efficiency in patient care—and in the process, positively impact thousands of patient lives. For more information, visit us online at www.absg.com, or contact us at marketing@absg.com.
	Campbell Alliance is the leading management consulting firm specializing in the pharmaceutical and biotechnology industry.  The firm's clients include most of the world's top-20 pharmaceutical companies, as well as numerous emerging and midsize firms.  Campbell Alliance is organized into practice areas, each specializing in a critical industry function:  Brand Management, Business Development, Clinical Development, Managed Markets, Medical Affairs, Sales, and Trade and Distribution.  From its locations in Raleigh, NC, Parsippany, NJ, Los Angeles, San Francisco, Chicago, Boston, Philadelphia, New York City, Atlanta, and Basel, the firm serves clients throughout North America, Europe, and Japan.  For more information on Campbell Alliance, please visit http://www.campbellalliance.com.
Supporting Sponsor:
Additional Sponsors:

For more information or to register, please contact the Center for Business Intelligence toll free by phone at 1-800-817-8601 or via e-mail at cbireg@cbinet.com.